Merck & Co (NYSE:MRK) Q4 2025 Earnings call February 03, 2026 09:00 AM ET Company ParticipantsCaroline Litchfield - CFODean Li - President of Research LaboratoriesEvan Seigerman - Managing Director and Head of Healthcare ResearchPeter Dannenbaum - SVP of Investor RelationsRob Davis - Chairman and CEOUmer Raffat - Senior Managing Director and Head of Large Cap Therapeutics ResearchConference Call ParticipantsAkash Tewari - Managing Director and Senior Equity Research AnalystAlex Hammond - Senior Biopharma Eq ...

FPGA Optimization - Addressing excessive pipeline depth in BN254 arithmetic logic on FPGA [1] - Targeting better timing closure and resource balancing [1] Future Updates - More updates to follow regarding BN254 pipeline optimization [1]